UK vaccine company Emergex has signed heads of terms for a collaboration with the Molecular Biology Institute of Paraná (IBMP) in Brazil: with the partnership covering Dengue, COVID-19 and Chikungunya vaccines.
Charles River and La Jolla Institute for Immunology (LJI) are collaborating on a new project to uncover how different cells in the human immune system respond to SARS-CoV-2 in early, acute infection.
Researchers have discovered a virus that is unable to replicate in humans and is ‘tolerant to genetic manipulation’ that could be used to protect humans from dangerous infectious diseases.